Healthcare provider profile · identity verified

Dmitriy M Acherkan, MD

Family Practice · CORALVILLE, IA · NPI 1952565368

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	177
Amlodipine Besylate	Amlodipine Besylate	360	100
Levothyroxine Sodium	Levothyroxine Sodium	349	88
Metoprolol Succinate	Metoprolol Succinate	330	89
Lisinopril	Lisinopril	285	86
Pravastatin Sodium	Pravastatin Sodium	257	68
Omeprazole	Omeprazole	237	71
Losartan Potassium	Losartan Potassium	225	70
Furosemide	Furosemide	187	61
Gabapentin	Gabapentin	178	39
Tamsulosin Hcl	Tamsulosin Hcl	173	53
Potassium Chloride	Potassium Chloride	169	36
Hydrochlorothiazide	Hydrochlorothiazide	146	45
Warfarin Sodium	Warfarin Sodium	141	22
Pantoprazole Sodium	Pantoprazole Sodium	138	35
Alendronate Sodium	Alendronate Sodium	123	36
Metformin Hcl	Metformin Hcl	123	36
Simvastatin	Simvastatin	116	34
Rosuvastatin Calcium	Rosuvastatin Calcium	110	32
Eliquis	Apixaban	105	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	30
Metoprolol Tartrate	Metoprolol Tartrate	103	25
Metformin Hcl Er	Metformin Hcl	92	30
Albuterol Sulfate Hfa	Albuterol Sulfate	91	26
Sertraline Hcl	Sertraline Hcl	87	27
Fluticasone Propionate	Fluticasone Propionate	86	30
Escitalopram Oxalate	Escitalopram Oxalate	82	16
Duloxetine Hcl	Duloxetine Hcl	80	16
Lovastatin	Lovastatin	76	18
Citalopram Hbr	Citalopram Hydrobromide	75	19
Tramadol Hcl	Tramadol Hcl	73	20
Azithromycin	Azithromycin	71	55
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	65	suppressed
Glimepiride	Glimepiride	65	20
Januvia	Sitagliptin Phosphate	61	17
Allopurinol	Allopurinol	59	19
Montelukast Sodium	Montelukast Sodium	57	18
Zolpidem Tartrate	Zolpidem Tartrate	56	11
Meloxicam	Meloxicam	54	12
Xarelto	Rivaroxaban	53	12
Carvedilol	Carvedilol	46	14
Cephalexin	Cephalexin	45	33
Famotidine	Famotidine	44	12
Clopidogrel	Clopidogrel Bisulfate	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	23
Clonazepam	Clonazepam	42	suppressed
Ozempic	Semaglutide	40	suppressed
Ezetimibe	Ezetimibe	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Trazodone Hcl	Trazodone Hcl	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	36	suppressed
Prednisone	Prednisone	36	29
Trulicity	Dulaglutide	36	suppressed
Farxiga	Dapagliflozin Propanediol	34	11
Lorazepam	Lorazepam	34	suppressed
Atenolol	Atenolol	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Novolog Flexpen	Insulin Aspart	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Finasteride	Finasteride	29	12
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Torsemide	Torsemide	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Baclofen	Baclofen	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Celecoxib	Celecoxib	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Primidone	Primidone	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Nystatin	Nystatin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Cefdinir	Cefdinir	12	12
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error